Home › Funds › Velan Capital Investment Management LP › TENX
Velan Capital Investment Management LP position in TENX
TENAX THERAPEUTICS INC · Health Care
Velan Capital Investment Management LP reported holding 68,700 shares of TENX (TENAX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$130K, representing 0.12% of its reported portfolio and ranking #41 among its reported holdings. Velan Capital Investment Management LP has disclosed TENX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's TENX position evolved
Velan Capital Investment Management LP first disclosed a stake in TENX in Q3 2024 at 83,333 shares (US$288K). The position peaked in Q1 2026 at 583,333 shares, worth US$9.3M. Across 9 filings, Velan Capital Investment Management LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 68,700 shares valued at US$130K. Notable position changes include a 600% increase in Q1 2026 (shares fell 9% over the following quarter), a 88% trim in Q2 2026 (shares fell 87% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 83.33K | $288.33K | New |
| Q4 2024 | 83.33K | $515.83K | Hold |
| Q1 2025 | 83.33K | $545.83K | Hold |
| Q2 2025 | 83.33K | $480.00K | Hold |
| Q3 2025 | 83.33K | $634.16K | Hold |
| Q4 2025 | 83.33K | $1.02M | Hold |
| Q1 2026 | 583.33K | $9.33M | Add |
| Q2 2026 | 68.70K | $999.59K | Reduce |
| Q3 2026 | 68.70K | $129.84K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TENX and 13F data
TENX (TENAX THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TENX — the largest reported positions include ADAR1 Capital Management, LLC (US$12.3M), BVF INC/IL (US$4.9M), Vivo Capital, LLC (US$4.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TENX
- ADAR1 Capital Management, LLC 6.52M sh · $12.33M · Q3 2026
- BVF INC/IL 339.55K sh · $4.94M · Q2 2026
- Vivo Capital, LLC 2.50M sh · $4.72M · Q3 2026
- Avidity Partners Management LP 265.93K sh · $3.87M · Q2 2026
- Stonepine Capital Management, LLC 588.00K sh · $1.11M · Q3 2026
- Jones Hill Capital LP 122.17K sh · $230.90K · Q3 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held TENX?
Velan Capital Investment Management LP has disclosed TENX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Velan Capital Investment Management LP's current position in TENX?
As of Q3 2026, Velan Capital Investment Management LP holds 68.70K shares of TENX (TENAX THERAPEUTICS INC), valued at $129.84K, representing 0.12% of its reported portfolio and ranking #41.
Has Velan Capital Investment Management LP been buying or selling TENX?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in TENX. The position peaked in Q1 2026 at 583.33K shares.
Which other funds hold TENX?
Other major institutional holders of TENX include ADAR1 Capital Management, LLC, BVF INC/IL, Vivo Capital, LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.